Meningitis News and Research

Latest Meningitis News and Research

Calgary doctors research how to minimize complications from Cryptococcus disease

Cryptococcus disease is a rare but serious infection resulting from inhaling a toxic fungus often found in fir trees. Approximately 250 people have been infected with the disease in British Columbia since its emergence in 1999. The disease can cause meningitis, pneumonia and in 10 per cent of cases it can lead to death.

5 May 2010

Children with hearing loss in one ear have poorer oral language scores: Study

By the time they reach school age, one in 20 children have hearing loss in one ear. That can raise significant hurdles for these children, say the results of a new study at Washington University School of Medicine in St. Louis, because loss of hearing in one ear hurts their ability to comprehend and use language.

5 May 2010

NIH awards $3.4M grant for preclinical development of novel Staphylococcus aureus vaccine

GlycoVaxyn AG, a leader in the development of innovative bioconjugate vaccines, and Professor Jean Lee, principal investigator at the Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, announced today that they have received a USD 3.4 million NIH grant to finance preclinical development of a novel Staphylococcus aureus vaccine. S. aureus is a major cause of hospital-based infections.

4 May 2010

New study reinforces urgent need for life-saving vaccines in Africa

A new study released this week in The Lancet Infectious Diseases finds that African children who contract pneumococcus - a bacterial infection that causes pneumonia, meningitis and sepsis - are 36 times as likely to have sickle-cell disease, a blood disorder prevalent in African children that increases the risk for infectious diseases and early death.

29 Apr 2010

ASPO meeting to focus on children's ear, nose and throat health

The American Society of Pediatric Otolaryngology will hold its annual meeting, April 30 - May 2, during the 2010 Combined Otolaryngology Spring Meetings - a joint meeting of eight otolaryngological societies in Las Vegas, NV.

27 Apr 2010

Canadians join hands in virtual community to raise awareness of meningitis and septicaemia

Canadians can join hands in a virtual community with the Meningitis Research Foundation of Canada and others around the globe to raise awareness of meningitis and septicaemia by visiting the Confederation of Meningitis Organizations web site - http://www.comoonline.org/JoiningHands.aspx.

24 Apr 2010

Deadly fungus on the move

Researchers revealed this Thursday that a deadly fungus that is usually found only in the tropics is making its way to the Pacific Coast of British Columbia and south into Washington, Oregon and Idaho.

23 Apr 2010

BUSM professor receives Individual Biomedical Research Award

Richard Goldstein, PhD, a professor of pediatrics, division of pediatric infectious diseases, at Boston University School of Medicine, has been awarded an Individual Biomedical Research Award by The Hartwell Foundation and will receive $300,000 over three years as a Hartwell Investigator for his project titled, "A Vaccine Against Streptococcus Pneumoniae Based on Bacterial Surface Proteins Phylogenically Certified as Highly Conserved."

23 Apr 2010

Bacterial infections often missed in febrile children in the ER

In a new study researchers reveal that up to one third of children with fever due to bacterial infections do not receive antibiotics in the emergency department and 20% of kids receive antibiotics unnecessarily.

22 Apr 2010

Hearing tests needed for children

The importance of hearing testing isn't widely understood by many parents. Parents may schedule appointments with an opthamologist for an eye exam for their children at regular intervals - but never think to similarly schedule a hearing test with an audiologist.

21 Apr 2010

Computerised diagnostic model outperforms clinical judgement for diagnosing children with febrile illness

A computerised diagnostic model outperforms clinical judgement for the diagnosis of fever in young children, and may improve early treatment, finds a study published on bmj.com today.

21 Apr 2010

Cal/OSHA issues $101,485 in citations to Alta Bates Summit Medical Center in Oakland

The Department of Industrial Relations' Division of Occupational Safety and Health, better known as Cal/OSHA, today issued $101,485 in citations to Alta Bates Summit Medical Center in Oakland for ten violations of the state safety and health standards in connection to a life-threatening exposure of bacterial meningitis.

20 Apr 2010

Nottingham and Japanese scientists to study genetic variation of E. coli bacteria

University of Nottingham scientists will join forces with Japan in the fight against a common bacterium - thanks to an international research award.

16 Apr 2010

Phase II GAMMAGARD clinical study for Alzheimer's disease: 18-month results announced

Baxter International Inc. and New York-Presbyterian Hospital/Weill Cornell Medical Center today announced results of an 18-month Phase II clinical study of GAMMAGARD LIQUID and GAMMAGARD S/D [Immune Globulin Intravenous (Human)] (marketed as KIOVIG outside of the U.S.) for mild-to-moderate Alzheimer's disease. This marked the first announcement of clinical trial results measuring function and cognition in patients who received uninterrupted GAMMAGARD for a period of 18 months.

From Baxter International Inc. 15 Apr 2010

Antibiotic-resistant pneumococci increase rate of bacterial infections in children

In the decade since the introduction of pneumococcal vaccination, significant shifts have occurred in the bacterial strains causing serious pneumococcal infections in children, according to a pair of studies in the April issue of The Pediatric Infectious Disease Journal (www.PIDJ.com). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

13 Apr 2010

Survey reveals Gamunex as preferred IGIV therapy among neurologists

Talecris Biotherapeutics, Inc., today announced results of a new survey showing that Gamunex® (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) is the preferred immune globulin intravenous (IGIV) among neurologists who indicated a brand preference. In the survey, conducted online by Harris Interactive® on behalf of Talecris, neurologists selected Gamunex over four times more often than all other available liquid IGIV therapies, with a statistically significant margin (p<0.05).

13 Apr 2010

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

Cempra Pharmaceuticals today announced poster presentations on its novel antibiotic CEM-101, a next-generation macrolide, and CEM-102, the company's proprietary front-loading oral dosing regimen of sodium fusidate, at the 20th European Congress of Clinical Microbiology and Infectious Disease, April 10 to 13, 2010, in Vienna Austria.

12 Apr 2010

Cepheid to launch GeneXpert Infinity-48 in Europe at 20th ECCMID

Cepheid will initiate European launch of its newest addition to the GeneXpert® family of molecular diagnostic testing systems, the GeneXpert Infinity-48, at the 20th annual European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Vienna, Austria. The GeneXpert Infinity-48 System is the world's first and only fully-automated, random-access system designed for management of the entire molecular testing workflow — from sample data, cartridge loading and unloading, to final reporting of test results and disposal of cartridges.

7 Apr 2010

Sinovac Biotech's fourth-quarter sales increase 194%

Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today its unaudited financial results for the three-month and preliminary twelve-month periods ended December 31, 2009.

6 Apr 2010

Health officials monitor cases of pandemic H1N1 flu in the Southeast

The continued spread of H1N1 influenza virus this spring is cause to pay heed to upper-respiratory maladies such as congestion, runny nose and cough, says David Kimberlin, M.D., a preeminent influenza specialist who co-directs the University of Alabama at Birmingham (UAB) Division of Pediatric Infectious Diseases.

6 Apr 2010

Meningitis News and Research

Latest Meningitis News and Research

Calgary doctors research how to minimize complications from Cryptococcus disease

Children with hearing loss in one ear have poorer oral language scores: Study

NIH awards $3.4M grant for preclinical development of novel Staphylococcus aureus vaccine

New study reinforces urgent need for life-saving vaccines in Africa

ASPO meeting to focus on children's ear, nose and throat health

Canadians join hands in virtual community to raise awareness of meningitis and septicaemia

Deadly fungus on the move

BUSM professor receives Individual Biomedical Research Award

Bacterial infections often missed in febrile children in the ER

Hearing tests needed for children

Computerised diagnostic model outperforms clinical judgement for diagnosing children with febrile illness

Cal/OSHA issues $101,485 in citations to Alta Bates Summit Medical Center in Oakland

Nottingham and Japanese scientists to study genetic variation of E. coli bacteria

Phase II GAMMAGARD clinical study for Alzheimer's disease: 18-month results announced

Antibiotic-resistant pneumococci increase rate of bacterial infections in children

Survey reveals Gamunex as preferred IGIV therapy among neurologists

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

Cepheid to launch GeneXpert Infinity-48 in Europe at 20th ECCMID

Sinovac Biotech's fourth-quarter sales increase 194%

Health officials monitor cases of pandemic H1N1 flu in the Southeast

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Meningitis News and Research

Latest Meningitis News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in